| Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non–small-cell lung cancer M Fukuoka, S Yano, G Giaccone, T Tamura, K Nakagawa, JY Douillard, ... Journal of clinical oncology 21 (12), 2237-2246, 2003 | 3981 | 2003 |
| The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells T Gutschner, M Hämmerle, M Eißmann, J Hsu, Y Kim, G Hung, A Revenko, ... Cancer research 73 (3), 1180-1189, 2013 | 1758 | 2013 |
| DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells MF Robert, S Morin, N Beaulieu, F Gauthier, IC Chute, A Barsalou, ... Nature genetics 33 (1), 61-65, 2003 | 793 | 2003 |
| Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss G Arun, S Diermeier, M Akerman, KC Chang, JE Wilkinson, S Hearn, ... Genes & development 30 (1), 34-51, 2016 | 598 | 2016 |
| Targeting nuclear RNA for in vivo correction of myotonic dystrophy TM Wheeler, AJ Leger, SK Pandey, AR MacLeod, M Nakamori, SH Cheng, ... Nature 488 (7409), 111-115, 2012 | 545 | 2012 |
| AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer D Hong, R Kurzrock, Y Kim, R Woessner, A Younes, J Nemunaitis, ... Science translational medicine 7 (314), 314ra185-314ra185, 2015 | 462 | 2015 |
| MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo M Fournel, C Bonfils, Y Hou, PT Yan, MC Trachy-Bourget, A Kalita, J Liu, ... Molecular cancer therapeutics 7 (4), 759-768, 2008 | 397 | 2008 |
| Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding AS Revenko, D Gao, JR Crosby, G Bhattacharjee, C Zhao, C May, ... Blood, The Journal of the American Society of Hematology 118 (19), 5302-5311, 2011 | 245 | 2011 |
| Inhibition of tumorigenesis by a cytosine–DNA, methyltransferase, antisense oligodeoxynucleotide S Ramchandani, AR MacLeod, M Pinard, E Von Hofe, M Szyf Proceedings of the National Academy of Sciences 94 (2), 684-689, 1997 | 236 | 1997 |
| Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk H Zhang, EC Löwenberg, JR Crosby, AR MacLeod, C Zhao, D Gao, ... Blood, The Journal of the American Society of Hematology 116 (22), 4684-4692, 2010 | 229 | 2010 |
| Regulation of DNA methylation by the Ras signaling pathway AR MacLeod, J Rouleau, M Szyf Journal of Biological Chemistry 270 (19), 11327-11337, 1995 | 225 | 1995 |
| An essential role for DNA methyltransferase DNMT3B in cancer cell survival N Beaulieu, S Morin, IC Chute, MF Robert, H Nguyen, AR MacLeod Journal of Biological Chemistry 277 (31), 28176-28181, 2002 | 218 | 2002 |
| Release of methyl CpG binding proteins and histone deacetylase 1 from the estrogen receptor α (ER) promoter upon reactivation in ER-negative human breast cancer cells D Sharma, J Blum, X Yang, N Beaulieu, AR Macleod, NE Davidson Molecular endocrinology 19 (7), 1740-1751, 2005 | 214 | 2005 |
| STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial MJ Reilley, P McCoon, C Cook, P Lyne, R Kurzrock, Y Kim, R Woessner, ... Journal for immunotherapy of cancer 6 (1), 1-10, 2018 | 210 | 2018 |
| Expression of Antisense to DNA Methyltransferase mRNA Induces DNA Demethylation and Inhibits Tumorigenesis (∗) AR MacLeod, M Szyf Journal of Biological Chemistry 270 (14), 8037-8043, 1995 | 201 | 1995 |
| Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS SJ Ross, AS Revenko, LL Hanson, R Ellston, A Staniszewska, N Whalley, ... Science translational medicine 9 (394), 2017 | 199 | 2017 |
| Regulation of the DNA Methyltransferase by the Ras-AP-1 Signaling Pathway (∗) J Rouleau, AR MacLeod, M Szyf Journal of Biological Chemistry 270 (4), 1595-1601, 1995 | 167 | 1995 |
| Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates JR Crosby, U Marzec, AS Revenko, C Zhao, D Gao, A Matafonov, ... Arteriosclerosis, thrombosis, and vascular biology 33 (7), 1670-1678, 2013 | 166 | 2013 |
| Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation FJ Reu, SI Bae, L Cherkassky, DW Leaman, D Lindner, N Beaulieu, ... J Clin Oncol 24 (23), 3771-3779, 2006 | 160 | 2006 |
| Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16ink4A and p21WAF/Cip1 by distinct mechanisms M Fournel, P Sapieha, N Beaulieu, JM Besterman, AR MacLeod Journal of Biological Chemistry 274 (34), 24250-24256, 1999 | 160 | 1999 |
